Close Menu

NEW YORK – Sample prep and diagnostic test technology developer Veravas said on Wednesday that it has raised $4 million from private investors through the issuance of convertible notes.

The Charleston, South Carolina-based company develops sample pretreatment products and diagnostic tests to provide laboratories with products for accurate diagnoses of diseases.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.